Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention (SAVI-PCI)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2015 by Medicure
SCRI Development Innovations, LLC
Information provided by (Responsible Party):
Medicure Identifier:
First received: January 27, 2012
Last updated: April 6, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)